Clareon CCWTT0 (UDI 00380652413473)Recalls & reported problems
Alcon Laboratories, Inc. · Clareon PanOptix UVA · Class 3 · Implant
All models of Clareon (1142)
Data updated Oct 16, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 5
- Deaths reported
- 0
- Injuries reported
- 5
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 5 adverse event reports that list this exact device (DI 00380652413473), received between Jun 13, 2023 and Sep 11, 2026 — classified as 5 injuries.
The most frequently reported specific device problem is “Explosion” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.
Reports received per month
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem5
- Explosion1
Patient problems
- Blurred Vision4
- Visual Disturbances2
- Visual Impairment2
- Dry Eye(s)1
- Halo1
- Posterior Capsule Opacification1
- Vitreous Floaters1
Recent adverse event reports
The 5 most recent of 5 reports, in the reporter's own words as published by the FDA.
InjurySep 11, 2026Adverse Event Without Identified Device or Use Problem
A non-health care professional reported that following an intraocular lens (IOL) implant procedure, the patient had blurred vision. The IOL was exchanged for unspecified Advanced Technology Intraocular Lens. Clinical reason for explant was mentioned as other mechanical complications of IOL.Additional information has been requested, received and stated the IOL was exchanged for another model same diopter company lens. There was no further patient impact.
Patient problems: Blurred Vision
MAUDE report 50734482 ↗InjuryJun 30, 2025Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
A NON-HEALTHCARE PROFESSIONAL REPORTED THAT FOLLOWING AN AGE RELATED CATARACT AND INTRAOCULAR LENS (IOL) IMPLANTATION PROCEDURE, THE PATIENT EXPERIENCED POOR QUALITY OF VISION, BLURRY VISION ALL THE RANGES WITH NO DISTANCE VISION, GLARE FROM LIGHT, HALOS AROUND BRIGHT LIGHT, RESIDUAL ASTIGMATISM, A LOT OF FLOATERS, KERATOCONJUNCTIVITIS SICCA/SOME DRYNESS, DECREASE CONTRAST SENSITIVITY AND PROGRESSIVE WORSENING OF VISION. SOME DRYNESS PRESCRIBED ARTIFICIAL TEARS (ATS) 4 TIMES DAILY. TROUBLE WITH DISTANCE VISION PRESCRIBED WITH GLASSES. FLOATERS WERE GREATLY STABLE. THE PATIENT HAD POSTERIOR CAPSULAR OPACIFICATION/SECONDARY CATARACT AND YTTRIUM ALUMINUM GARNET (YAG) WAS PLANNED. THE PATIENT WAS OK WITH READERS, BUT REPORTS QUALITY OF VISION WAS LIMITED. SURGEON DISCUSSED RISK OF IOL EXCHANGE. THE OLD LENS WAS FREED WITH VISCOELASTIC AND MOBILIZED INTO THE ANTERIOR CHAMBER. THE OLD LENS WAS CUT IN HALF AND REMOVED WITHOUT COMPLICATIONS. CAPSULAR BAG WAS EXTENDED AND ANOTHER MODEL SAME COMPANY LENS WITH DIFFERENT DIOPTER WAS INJECTED WITH NON-COMPANY CAPSULAR TENSION RING BECAUSE OF POOR DILATION 5 MONTHS 12 DAYS FOLLOWING THE INITIAL IMPLANT PROCEDURE. ADDITIONAL INFORMATION HAS BEEN
Patient problems: Blurred Vision; Dry Eye(s); Posterior Capsule Opacification; Visual Disturbances; Visual Impairment; Vitreous Floaters
MAUDE report 22353024 ↗InjuryJan 9, 2025Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
A FACILITY REPRESENTATIVE REPORTED THAT FOLLOWING INTRAOCULAR LENS (IOL) IMPLANT PROCEDURE, THERE WAS NO IMPROVEMENT IN DISTANCE AND NEAR VISION. PATIENT HAD PROBLEMS WHILE WORKING, WALKING AND READING. THE LENS WAS EXCHANGED FOR AN UNKNOWN ADVANCED TECHNOLOGY INTRAOCULAR LENS (ATIOL) AFTER THE INITIAL IMPLANT PROCEDURE. THE CLINICAL REASON FOR EXPLANTATION WAS PATIENT UNHAPPY WITH VISION.
Patient problems: Blurred Vision
MAUDE report 21108736 ↗InjuryDec 7, 2024Adverse Event Without Identified Device or Use Problem; Explosion; Adverse Event Without Identified Device or Use Problem; Explosion
A NON-HEALTHCARE PROFESSIONAL REPORTED THAT FOLLOWING AN INTRAOCULAR LENS (IOL) IMPLANT PROCEDURE, THE PATIENT EXPERIENCED BLURRY VISION. THE LENS WAS EXCHANGED FOR ANOTHER LENS MODEL 2 MONTHS FOLLOWING THE INITIAL PROCEDURE. CLINICAL REASON FOR EXPLANT WAS MENTIONED AS LENS NOT COMPATIBLE WITH THE PATIENT.
Patient problems: Blurred Vision; Visual Impairment
MAUDE report 20873468 ↗InjuryJun 13, 2023Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
ADDITIONAL INFORMATION RECEIVED AND REPORTED THAT THE IOL WAS EXCHANGED FOR THE DIFFERENT LENS MODEL AND HALF A DIOPTER MORE POWER INDICATING THE CORRECT LENS POWER WAS NOT IMPLANTED INITIALLY. THERE IS NO REPORTED DEFECT OR FAULT WITH THE IOL.
Patient problems: Halo; Visual Disturbances
MAUDE report 17117167 ↗
Other intraocular lens devices
- TECNIS IOL PCB00Johnson & Johnson Surgical Vision, Inc. · intraocular lens146 reports
- TECNIS IOL PCB00Johnson & Johnson Surgical Vision, Inc. · intraocular lens145 reports
- TECNIS IOL PCB00Johnson & Johnson Surgical Vision, Inc. · intraocular lens144 reports
- TECNIS IOL PCB00Johnson & Johnson Surgical Vision, Inc. · intraocular lens139 reports
- TECNIS SIMPLICITY DIB00Johnson & Johnson Surgical Vision, Inc. · intraocular lens1 recall81 reports
- TECNIS IOL PCB00Johnson & Johnson Surgical Vision, Inc. · intraocular lens129 reports
- TECNIS IOL PCB00Johnson & Johnson Surgical Vision, Inc. · intraocular lens127 reports
- TECNIS IOL PCB00Johnson & Johnson Surgical Vision, Inc. · intraocular lens126 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page